Investor Consortium and NEA to Take NeueHealth Private
Investor Consortium and NEA to Take NeueHealth Private Investor Consortium, led by New Enterprise Associates (NEA), has announced that it has entered into a definitive merger agreement to acquire NeueHealth, Inc. (NYSE: NEUE), a value-driven healthcare company, for approximately $1.3…
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company focused on developing innovative treatments for acute cannabinoid-induced toxicities, has announced a positive regulatory update and the successful completion of a…
Refinancing plan unveiled by MultiPlan to strengthen its capital structure
Refinancing plan unveiled by MultiPlan to strengthen its capital structure MultiPlan Corporation (NYSE: MPLN), a prominent provider of technology and data solutions dedicated to cost management, quality improvement, and transparency in healthcare, has announced a comprehensive refinancing initiative. This refinancing…
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials Proton Intelligence Inc., the developer of the innovative Continuous Potassium Monitoring (CKM™) platform, has successfully closed a $6.95 million USD Seed Financing round. The round was supported by investors including…
Approval Granted for SOLVD Health’s New York State Laboratory
Approval Granted for SOLVD Health’s New York State Laboratory SOLVD Health, a patient intelligence company specializing in advanced precision solutions to improve health outcomes, has received approval from the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP)…
Cervical Cancer: NERLYNX® Added to NCCN Guidelines for HER2-Mutation
Cervical Cancer : NERLYNX® Added to NCCN Guidelines for HER2-Mutation Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company focused on advancing cancer treatments, has announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Cervical Cancer have been…
Allurion Technologies Announces Reverse Stock Split
Allurion Technologies Announces Reverse Stock Split Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, has announced that its Board of Directors has approved a one-for-twenty-five reverse stock split of the Company’s common stock, effective January 3, 2025.…
ASPIRE Level 1: SURE Procedure with CVAC Outperforms Standard Ureteroscopy
ASPIRE Level 1: SURE Procedure with CVAC Outperforms Standard Ureteroscopy Calyxo, Inc., a medical device company focused on innovative solutions for kidney stone treatment, today announced the publication of the full 30-day outcomes from the ASPIRE (ASPiration to Improve Renal…
Clinical Trials: Ellipse Launches Program in the Middle East
Clinical Trials: Ellipse Launches Program in the Middle East Ellipses Pharma Limited, a global drug development company focused on advancing cancer treatments, has launched its first large-scale Phase 1/2 oncology clinical trial in the United Arab Emirates (UAE). This significant…
Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor
Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor Encompass Health Corp. (NYSE: EHC) has unveiled plans to construct a new 50-bed, freestanding inpatient rehabilitation hospital in Bangor, Maine, aimed at providing specialized care for patients recovering…
Henry Schein Celebrates the Season of Giving
Henry Schein, Inc. (Nasdaq: HSIC), along with Team Schein Members (TSMs) from around the globe, is once again brightening the holiday season through its 26th annual “Holiday Cheer” program. This year, the initiative brought joy to over 1,150 individuals in…
Cardinal Health Begins Routine Actinium-225 Production at Theranostics Center
Cardinal Health (NYSE: CAH) has announced the initiation of weekly actinium-225 (Ac-225) production at its Center for Theranostics Advancement in Indianapolis, Indiana. This milestone follows a collaboration with TerraPower Isotopes and marks a significant step in expanding the availability of…